中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming;  Wang, Xiao-Jia;  Shao, Xi-Ying
收藏  |  浏览/下载：40/0  |  提交时间：2021/11/01
Advanced breast cancer (ABC)  aromatase inhibitors (AIs)  everolimus (EVE)  fulvestrant (FUL)  retrospective study  
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
收藏  |  浏览/下载：33/0  |  提交时间：2020/10/26
PHASE-I  POSTMENOPAUSAL WOMEN  HDAC INHIBITOR  MULTICENTER  ENTINOSTAT  TAMOXIFEN  CS055/HBI-8000  RESISTANCE  LETROZOLE  TRIAL  Advanced breast cancer  hormone receptor-positive  chidamide  exemestane